PATENT CLAIM ANALYSIS

Application Number: 15952934
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to solid oral formulations comprising a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one-O-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. The present invention is furthermore related to processes for their preparation.

Claim (Index 3):
The method of  claim 2 , wherein the carrier is selected from the group consisting of calcium silicate, calcium carbonate, calcium phosphate, tribasic calcium phosphate, lactose, starch, modified starch, sugars, celluloses, cellulose derivatives, polymethacrylates, chitin, chitosan, and combinations thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14571615', '15476325', '14735215', '14479664', '15938729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.843940051979097
- 35 USC 102 Novelty (BERT): 0.548180813144263
- Combined Prediction Score: 0.8143641280956136
- Mean Citation Score: 405.22407600000014
- Max Citation Score: 476.6411
- Similarity Product: 260.9506109998227

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test